Alimera Sciences, Inc. (ALIM)의 가격은 얼마입니까?

Alimera Sciences, Inc. (ALIM)의 가격은 $5.54입니다.

Alimera Sciences, Inc. (ALIM)의 시가 총액은 무엇입니까?

Alimera Sciences, Inc. (ALIM)의 시가 총액은 $38.76M입니다.

Alimera Sciences, Inc. (ALIM) 주당순이익

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

연도	EPS	변화
2026 (TTM)	$-0.28	-64.56%
2023	$-0.79	-69.50%
2022	$-2.59	292.42%
2021	$-0.66	-36.54%
2020	$-1.04	-52.51%
2019	$-2.19	-158.40%
2018	$3.75	-176.06%
2017	$-4.93	-47.66%
2016	$-9.42	-8.90%
2015	$-10.34	-22.43%
2014	$-13.33	-45.14%
2013	$-24.30	158.24%
2012	$-9.41	-12.63%
2011	$-10.77	61.95%
2010	$-6.65	-98.48%
2009	$-437.12	-23.24%
2008	$-569.46	977.30%
2007	$-52.86	-56.02%
2006	$-120.18	0.00%

연도

EPS

변화

2026 (TTM)

$-0.28

-64.56%

2023

$-0.79

-69.50%

2022

$-2.59

292.42%

2021

$-0.66

-36.54%

2020

$-1.04

-52.51%

2019

$-2.19

-158.40%

2018

$3.75

-176.06%

2017

$-4.93

-47.66%

2016

$-9.42

-8.90%

2015

$-10.34

-22.43%

2014

$-13.33

-45.14%

2013

$-24.30

158.24%

2012

$-9.41

-12.63%

2011

$-10.77

61.95%

2010

$-6.65

-98.48%

2009

$-437.12

-23.24%

2008

$-569.46

977.30%

2007

$-52.86

-56.02%

2006

$-120.18

0.00%

회사	EPS	EPS 차이	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-298.68%	IN

회사

EPS

EPS 차이

국가